Location History:
- Martinez, GA (US) (2000 - 2002)
- Nashville, TN (US) (2004 - 2010)
Company Filing History:
2 out of 49 
1 out of 1,153 
1 out of 832,812 Years Active: 2000-2010
Title: Innovations in Gastrointestinal Cancer Screening by James R Goldenring
Introduction
James R Goldenring is a notable inventor based in Nashville, TN, who has made significant contributions to the field of gastrointestinal cancer research. With a total of four patents to his name, Goldenring's work focuses on innovative methods for diagnosing and screening for gastrointestinal cancers, particularly gastric adenocarcinoma.
Latest Patents
Goldenring's latest patents include groundbreaking methods for screening and diagnosing upper gastrointestinal cancers. One of his patents outlines methods for diagnosing upper GI cancer by determining the levels of specific biomarkers in biological samples. This approach allows for the assessment of whether to initiate or continue treatment based on measurable changes in biomarker levels over time. Another significant patent involves the identification of a specific metaplastic lineage associated with gastric adenocarcinoma. This lineage, characterized by immunoreactivity for a trefoil polypeptide known as spasmolytic peptide, is crucial for grading stomach biopsies and assessing cancer risk. The use of antibodies to spasmolytic peptide in immunostaining provides a rapid detection method for identifying at-risk patients.
Career Highlights
Throughout his career, Goldenring has worked with esteemed institutions such as the Medical College of Georgia Research Institute and Vanderbilt University. His research has not only advanced the understanding of gastrointestinal cancers but has also paved the way for new diagnostic techniques that can potentially save lives.
Collaborations
Goldenring has collaborated with notable colleagues, including Jeffrey Roberts Lee and P Henry Schmidt, contributing to a rich exchange of ideas and innovations in the field of cancer research.
Conclusion
James R Goldenring's contributions to gastrointestinal cancer screening represent a significant advancement in medical diagnostics. His innovative methods and collaborative efforts continue to impact the field positively, offering hope for improved patient outcomes in the fight against cancer.